| Antigen | 13-aa peptide from human Nogo-A (1); Designation (#NOGOA12-P, control/blocking peptide) conjugated to KLH; epitope location ~ between the putative 2nd-3rd transmembrane domain |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | The human NogoA12-P peptide sequence is conserved in all 3 isoforms (human Nogo A-C). It is 92% identical in mouse, rat Nogo or rat foocen-m1/2 protein and 100% in monkey Nogo-A. NogoA12-P is within the 25-aa region identified for the inhibition of neurite outgrowth (1). Antibody crossreactivity of NogoA12 in various species is not established |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |